Acute Porphyria Drug Database

Monograph

J01DE01 - Cefepime
Propably not porphyrinogenic
PNP

Rationale
In greater part not metabolised. No clinical or experimental data pointing to CYP-interaction. Two references consider the drug safe or probably safe.
Chemical description
Parenterally administered cephalosporin used in serious pneumonia, serious infections outgoing from the lungs and serious intra abdominal infections. About 85% is excreted in unchanged form in urine. About 8% is excreted as primary or secondary metabilites. French list: use. South African list: use with caution. See: Jordan MC et al. Effect of cephalosporins.. (PMID 8140590) ( No induction of CYPs observed in animal study.)
Similar drugs
Explore alternative drugs in similar therapeutic classes J01D / J01DE or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Cefepim · Cefepime Cefepim · Cefepime Cefepima Cepim · Cepimex Cefepima · Cefepime Renapime Cefepim Cefepim Cefepim · Cefepime Cefepime Cefepim Cefepime · Salapime Cefepim · Cefepima · Cefim · Verapime
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙